BMGAX
Price
$36.48
Change
-$1.58 (-4.15%)
Updated
Feb 21 closing price
Net Assets
10.2B
PMBPX
Price
$44.27
Change
-$0.76 (-1.69%)
Updated
Feb 21 closing price
Net Assets
30.08B
Ad is loading...

BMGAX vs PMBPX

Header iconBMGAX vs PMBPX Comparison
Open Charts BMGAX vs PMBPXBanner chart's image
BlackRock Mid-Cap Growth Equity Inv A
Price$36.48
Change-$1.58 (-4.15%)
VolumeN/A
Net Assets10.2B
Principal MidCap R5
Price$44.27
Change-$0.76 (-1.69%)
VolumeN/A
Net Assets30.08B
BMGAX vs PMBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMGAX vs. PMBPX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMGAX is a Hold and PMBPX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 30.1B vs. BMGAX (10.2B). BMGAX (0.00) and PMBPX (0.00) have matching dividends . BMGAX was incepted earlier than PMBPX: BMGAX (28 years) vs PMBPX (24 years). BMGAX is a more actively managed with annual turnover of: 46.00 vs. PMBPX (10.10). PMBPX has a lower initial minimum investment than BMGAX: PMBPX (0) vs BMGAX (1000). PMBPX annual gain was more profitable for investors over the last year : 17.07 vs. BMGAX (15.61). PMBPX (38.64) and BMGAX (37.61) have equivalent 5 years return.
BMGAXPMBPXBMGAX / PMBPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years24 years-
Gain YTD6.7414.533149%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets10.2B30.1B34%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.6117.0791%
Returns for 3 years18.0129.5161%
Returns for 5 years37.6138.6497%
Returns for 10 years150.7197.51155%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BALY17.330.44
+2.61%
Bally's Corporation
BIO285.631.90
+0.67%
Bio-Rad Laboratories IncClass A
GPUS3.150.02
+0.64%
Hyperscale Data Inc
PTGX38.49-0.04
-0.10%
Protagonist Therapeutics
MIST2.06-0.07
-3.29%
Milestone Pharmaceuticals